Advertisement

Topics

Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment

02:40 EDT 10 Aug 2017 | Pharmaceutical Business Review

Cancer Research UK has collaborated with Biotecnol to start early phase clinical trials for new immuno-oncology treatment, Tb535H.

Original Article: Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment

NEXT ARTICLE

More From BioPortfolio on "Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...